Iovance Biotherapeutics | ARS: Annual Report to Security Holders
Iovance Biotherapeutics | DEFA14A: Others
Iovance Biotherapeutics | DEF 14A: Definitive information statements
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vogt Frederick G
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GRAF FINCKENSTEIN FRIEDRICH
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BILINSKY IGOR
Iovance Biotherapeutics | 8-K: Current report
Iovance Biotherapeutics | 8-K: Current report
Iovance Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Quogue Capital LLC(11.6%),Wayne P. Rothbaum(11.6%)
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vogt Frederick G
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GRAF FINCKENSTEIN FRIEDRICH
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BILINSKY IGOR
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Maynard Ryan D
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vogt Frederick G
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rothbaum Wayne P.
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director YARNO WENDY L
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director WEISER MICHAEL
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director MCPEAK MERRILL A
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dukes Iain D.
Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Countouriotis Athena
No Data